You just read:

BrainStorm Announces Final Analysis of Phase 2a ALS Study Showing Nearly All Subjects Experienced Clinical Benefit from NurOwn™

News provided by

BrainStorm Cell Therapeutics Inc.

Jan 05, 2015, 08:20 ET